I Tried Everything — Ozempic, Liposuction, Everest

Dear Traders,

It’s been a while since I last wrote you a newsletter, and I wanted to give you a quick update on what’s been going on in my life.

First off, as we all know, obesity has become a new epidemic around the world. It’s a real issue, and a lot of people are trying to figure out how to deal with it. Personally, even though I’m pretty active — running, climbing mountains, staying fit — I still struggle with some health challenges. I have high cholesterol, and my blood is slightly lipidemic, so staying healthy and watching my food has always been a big part of my recent life.

Growing up, both of my parents were overweight, and honestly, I was pretty out of shape too. It’s been a long journey for me dealing with obesity — I tried extreme hunger, fasting, even liposuction (once in London, and once in Colombia). I also gave weight-loss drugs like Ozempic a shot.

When I used Ozempic, it actually worked really well for weight loss, but I hated two things about it:

• I lost a lot of muscle.
• I had serious side effects that made it hard to stick with.

Recently, a new company caught my attention: Northstrive Biosciences. They are a 100% owned subsidiary of PMGC Holdings and are trading publicly on Nasdaq under the ticker ELAB.

What’s exciting about them is they’re developing a novel therapeutic focused on muscle preservation, specifically designed to be used in combination with GLP-1s like Ozempic. While GLP-1s promote fat loss, they can also lead to unwanted muscle loss.

Northstrive’s candidate, a myostatin inhibitor, aims to counteract this by helping preserve lean muscle mass during treatment. Northstrive recently received FDA guidance enabling the submission of an Investigational New Drug (IND) application for a Phase 2 clinical trial. This key regulatory milestone validates the company’s approach and sets the stage for advancing its myostatin inhibitor into the next phase of clinical development.

Here’s a Reuters article that talks about this new direction in weight loss treatments in the article “Fat, not muscle: Drugmakers race for next weight-loss breakthrough.”

After reading about it, I actually sat down with Northstrive’s Co-Founder, Deniel Mero, for an interview, and we had a fascinating conversation about their technology and vision. I’m super excited to see where this goes.

As a quick disclaimer: I might personally invest in some shares of ELAB next week. Just sharing this because I always want to stay transparent with you. Read the full disclaimer here.

Also, I recorded my full interview with Deniel, and the video is currently being edited. I’ll share it with you next week once it’s ready!

Tomorrow, I’m flying to China, and I’ll be spending a week in Beijing. Surprisingly, even though I’ve been to China several times, I’ve never been to Beijing before. I’ve visited Shanghai, Chengdu, and also traveled out west to the Himalayan regions of China, including an unforgettable trip to Tibet and its capital, Lhasa.

China has always amazed me. Even though it’s a country that many Westerners don’t visit often, mainly because the system is different, I’ve really enjoyed my experiences there. China has seen incredible growth over the last 30 to 40 years, probably faster than any other major economy. Their middle class has exploded, and this economic transformation has put China right in the center of the global trade debates we hear so much about, especially during President Trump’s administration and the ongoing discussions around the global trade wars.

Now, I don’t want this newsletter to lean too heavily in any political direction. But it’s hard not to notice that part of the tension in global politics today stems from the fact that the middle class in Western democracies hasn’t always benefited from the post-Cold War global order. Especially after the pandemic, a lot of voters in Europe and North America shifted more toward right-leaning political movements. It makes sense when you think about how inflation and economic pressures can push people to seek change.

It’s a fascinating time to witness — a possible global economic reordering happening right in front of our eyes. When the April 2nd, 2025 “Liberation Day” happened, we saw a massive selloff in the stock markets, which was somewhat expected. But what caught a lot of attention was that the bond market also sold off aggressively.

That’s usually not a good sign. U.S. Treasuries are considered one of the safest assets in the world, and if investors start selling them, it means they’re losing confidence.

The spike in 10-year Treasury yields showed that fear. And the White House took notice. President Trump even commented that the bond market’s reaction was not healthy for the global economy. It’s important to remember: while the Federal Reserve can control short-term interest rates, they can’t control the 10-year yields — that’s entirely up to market forces. And when investors are worried about growth or about the U.S. being able to pay its debts, they might dump Treasuries and buy safer assets like gold, which is exactly what we’ve seen happening recently.

Honestly, when I first started trading, I never really cared much about macroeconomics. But after the pandemic, it became impossible to ignore how much these big global forces affect our day-to-day trading. I’m slowly learning more and more about it and trying to fold it into my own trading approach.

One More Thing: Our Next Bootcamp Starts in One Week!

I’m really excited that in just one week, we kick off our next Bear Bull Traders Bootcamp, and honestly, this is the most comprehensive program we’ve ever built. This Bootcamp is focused on showing how powerful mentorship, community support, and consistent practice are for developing successful traders. There’s no secret sauce to trading, the more you put in, the more you get out.

In this Bootcamp, you’ll get:

• Daily live trading sessions with Avi, Thor, and other senior traders, in addition to access to Carlos and Peter’s live sessions on YouTube, plus private trading sessions with Brian and me in the chatroom.
• Real exposure to day trading options and Thor’s Volume Price Analysis (VPA) strategy.
• The Bootcamp package is priced at $2,999 and includes:
• One year of Bear Bull Traders membership
• Three months of DAS Simulator access
• Three months of a funded trading account (after qualifying)
• One full Bootcamp session
• Access to private and semi-private mentorship groups

Last Spots Available – Register Now
If you have any questions, feel free to reply to this email or reach out directly to Mike@PeakCapitalTrading.com. We’d love to have you join us and take your trading to the next level!

To your success and health!

Andrew

P.S. As mentioned earlier, this newsletter is sponsored by PCMG Holdings and Northstrive Biosciences. Please check out the disclaimer for full transparency!